Based on interview and record review, the facility failed to ensure a Preadmission Screening and Resident Review (PASARR) was completed for 1 of 4 residents reviewed for PASARR. (Resident 13)Findings include:The clinical record for Resident 13 was reviewed on 3/12/26 at 11:25 a.m. The diagnoses included, but were not limited to, Parkinsonism, major depressive disorder, and dementia.A physician's order, dated 10/3/25, indicated to administer escitalopram (an antidepressant medication) 5 milligrams (mg) for depression.A physician's order, dated 10/3/25, indicated to administer quetiapine (an antipsychotic medication) 50 mg for depression.There was no PASARR screening located in Resident 13's clinical record.During an interview, on 3/12/26 at 10:35 a.m., Clinical Support Nurse 1 indicated the… …
F645 citations in Indiana
PASARR screening · Resident Assessment and Care Planning Deficiencies
PASARR screening for Mental disorders or Intellectual Disabilities
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Indiana cites F645 less often than its own record predicts
0.42 times the national share — cited less often here than elsewhere.
Of every deficiency written in Indiana in 2025, this is the portion that was F645.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Indiana surveyors wrote
F645 findings written in Indiana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Indiana citations | vs expected |
|---|---|---|
| 2024 | 0.08% | 0.12× |
| 2025 | 0.25% | 0.42× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Indiana surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction